Influence of gut bacteria on type 2 diabetes: Mechanisms and therapeutic strategy

被引:3
|
作者
Wen, Xue [1 ]
Qi, Lu-Ming [1 ]
Zhao, Kui [2 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Coll Hlth & Rehabil, Chengdu 610000, Sichuan, Peoples R China
[2] Southwest Forestry Univ, Coll Mat & Chem Engn, 300 White Dragon Temple, Kunming 650224, Yunnan, Peoples R China
关键词
Type; 2; diabetes; Intestinal microbiome; Intestinal axis; Biological pathways; Treatment; Short-chain fatty acids; P-CRESYL SULFATE; INSULIN SENSITIVITY; INDIGENOUS BACTERIA; MICROBIOTA; MODULATION; PROBIOTICS; RECEPTOR; OBESITY;
D O I
10.4239/wjd.v16.i1.100376
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The onset and progression of type 2 diabetes mellitus (T2DM) are strongly associated with imbalances in gut bacteria, making the gut microbiome a new potential therapeutic focus. This commentary examines the recent publication in World Journal of Diabetes. The article explores the association between T2DM and gut microbiota, with a focus on the pathophysiological changes related to dysbiosis. It proposes innovative microbiome-targeted therapeutic strategies and evaluates the challenges and future directions of such approaches. This editorial summarizes the key points of their discussion of the role of the gut microbiome in T2DM and elaborates on the influence of specific gut microbial species on the disease through the host-microbiota metabolic axis. It provides new insights for future research on gut-microbiota-based interventions for T2DM.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Gut microbiota and type 2 diabetes mellitus
    Munoz-Garach, Araceti
    Diaz-Perdigones, Cristina
    Tinahones, Francisco J.
    ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (10): : 560 - 568
  • [2] Type 2 diabetes and gut health - Narrative review
    Lunghar, Janeline
    Banu, A. Thahira
    INTERNATIONAL JOURNAL OF NONCOMMUNICABLE DISEASES, 2024, 9 (01) : 4 - 12
  • [3] Examining the benefits of cold exposure as a therapeutic strategy for obesity and type 2 diabetes
    Ivanova, Yoanna M.
    Blondin, Denis P.
    JOURNAL OF APPLIED PHYSIOLOGY, 2021, 130 (05) : 1448 - 1459
  • [4] Gut microbiota is a factor of risk for obesity and type 2 diabetes
    Demidova, T. Y.
    Lobanova, K. G.
    Oinotkinova, O. S.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (10) : 97 - 104
  • [5] New therapeutic strategy for type 2 diabetes
    Mrozowski, Jean Michal
    ACTUALITES PHARMACEUTIQUES, 2025, 64 (642): : 44 - 46
  • [6] Gut microbiome: New perspectives for type 2 diabetes prevention and treatment
    Li, Shu-Xiao
    Guo, Yan
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (31) : 7508 - 7520
  • [7] Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy
    Stefater, M. A.
    Inge, T. H.
    CURRENT DIABETES REPORTS, 2017, 17 (08)
  • [8] Remote ischemic conditioning: A potential therapeutic strategy of type 2 diabetes
    Liu, Jie
    Sun, Xin
    Jin, Hang
    Yan, Xiu-Li
    Huang, Shuo
    Guo, Zhen-Ni
    Yang, Yi
    MEDICAL HYPOTHESES, 2021, 146
  • [9] Therapeutic mechanisms of mulberry leaves in type 2 diabetes based on metabolomics
    Ma, Quantao
    Li, Yaqi
    Zhao, Ruixue
    Tang, Ziyan
    Li, Jialin
    Chen, Cong
    Liu, Xiaoyao
    Hu, Yujie
    Wang, Ting
    Zhao, Baosheng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Gut microbiota and therapy for obesity and type 2 diabetes
    Zhang, Luyao
    Wang, Pai
    Huang, Juan
    Xing, Yanpeng
    Wong, F. Susan
    Suo, Jian
    Wen, Li
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15